| FDA Approves Feraheme to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients (Business Wire via Yahoo! Finance) |
|
|
LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted marketing approval for Feraheme™ Injection for intravenous use as an iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease. |